Amylyx Pharmaceuticals, Inc. (AMLX) FDA catalysts & readout calendar Updated August 24, 2026 · next FDA decision on the calendar Amylyx Pharmaceuticals, Inc. · no upcoming catalyst on file · 0 past FDA decisions
Clinical readouts (1) Aug 18, 2026✓ Positive Avexitide See the full 2026 PDUFA calendar → This page aggregates AMLX's FDA catalysts from pdufa.bio's own calendar and decision archive. Each item links to its source page. Facts and dates only; verify against primary FDA / SEC / company filings.
Not affiliated with or endorsed by the FDA. pdufa.bio is an independent publication with no affiliation with, endorsement by, sponsorship by, or connection to the U.S. Food and Drug Administration or any other government agency. “FDA”, “PDUFA” and all company, drug and ticker names are used descriptively and remain the property of their respective owners.Informational and educational purposes only. Not investment advice. Nothing on this page is investment, legal, tax or medical advice, or an offer or solicitation to buy or sell any security. pdufa.bio is not a registered investment adviser or broker-dealer and does not recommend trades or publish individual-drug approval probabilities. Verify every date and outcome against primary FDA, SEC or company filings. Data is provided as is, without warranty of any kind, and past behaviour does not predict future outcomes.